• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Cancer Therapeutics

Cancer Therapeutics

  1. Research and Markets: Squamous Non-Small Cell Lung Cancer Pipeline Insights Report 2015

    Research and Markets: Squamous Non-Small Cell Lung Cancer Pipeline Insights Report 2015

  2. Research and Markets: Cancer Immunotherapy Overview: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies

    Research and Markets: Cancer Immunotherapy Overview: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies

  3. Aptose Biosciences Doses First Patient in Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Malignancies

    Aptose Biosciences Doses First Patient in Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Malignancies

  4. Research and Markets: Global Non Small Cell Lung Cancer Market & Pipeline Insight 2015 - 268 Drugs With 99 in Phase-II Trials and 30 Marketed NSCLC Drugs

    Research and Markets: Global Non Small Cell Lung Cancer Market & Pipeline Insight 2015 - 268 Drugs With 99 in Phase-II Trials and 30 Marketed NSCLC Drugs

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.